Novartis Group
Sosei R&D Ltd. licensed exclusive worldwide development and commercialization rights for NVA237 to Novartis in a deal announced 13 April 2005.
* For more information regarding this alliance, please
go to the news release
ASKA Pharmaceuticals
In November 2009 Sosei signed an agreement for the commercialization of the emergency contraceptive pill NorLevo®.
* For more information regarding this alliance, please
go to the news release
